Company Filing History:
Years Active: 2010-2015
Title: Lone Kjær Rasmussen: Innovator in Recombinant Polyclonal Antibodies
Introduction
Lone Kjær Rasmussen is a distinguished inventor based in Skodsborg, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polyclonal antibodies. With a total of 2 patents, his work has advanced the understanding and application of polyclonal cell lines in therapeutic contexts.
Latest Patents
Rasmussen's latest patents include a procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line. This invention provides a structural characterization platform that can assess the stability of a polyclonal cell line during production, as well as batch-to-batch consistency of the final polyclonal products. The platform utilizes genetic analysis and protein characterization techniques to gather essential information for characterizing both the polyclonal cell line and its final products. Another notable patent is the anti-orthopoxvirus recombinant polyclonal antibody, which comprises distinct members capable of binding at least three orthopoxvirus-related antigens. This patent also includes a pharmaceutical composition comprising the antibody and methods for its production.
Career Highlights
Lone Kjær Rasmussen is currently associated with Symphogen A/S, where he continues to innovate in the field of recombinant proteins. His work has been pivotal in developing therapeutic methods utilizing polyclonal antibodies, contributing to advancements in medical treatments.
Collaborations
Rasmussen has collaborated with notable colleagues such as Søren Kofoed Rasmussen and Allan Jensen. These partnerships have fostered a collaborative environment that enhances research and development in their shared field of expertise.
Conclusion
Lone Kjær Rasmussen's contributions to biotechnology, particularly in the realm of recombinant polyclonal antibodies, underscore his role as a leading inventor. His innovative patents and collaborative efforts continue to impact the field positively.